Explore more publications!

Press Releases

Skylark, Gibbs & Redmond Unveil LOSTSHDWS’ Breakout Art–Fashion Moment, Defining a New Black Creative Vanguard at Basel
Roadzen to Showcase DrivebuddyAI as First-Time Exhibitor at CES 2026 (January 6 – 9)
In New York’s Overloaded Dating Scene, New Matchmaking Service MYA Bets on Safety and Serious Intentions
Groundbreaking for SPARC Kips Bay

Groundbreaking for SPARC Kips Bay

Tri by Lili Gendelman Wins Silver in A' Toy, Game and Hobby Products Design Award
Rezolve Ai Accelerates Global Momentum with Live Enterprise Deployments, Major Renewals and Expanding Pipeline into 2026
Cristina Fontanelli's 22nd-annual 'Christmas in Italy®' concert NYC to be presented in historic and miraculous church
Sustainable Media Center Expands Board of Advisors with Parent Advocates and New Gen Z Leaders
Giordano’s Celebrates Chicago Sports History With “Da Pizza,” A Limited-Edition Pie Honoring The City’s Legendary 1985 Champs
Thor Equities Chairman Joe Sitt Discusses AI Investment Surge and New York’s Future on Bloomberg TV
Influential Women Spotlights Kara Fischer: A Visionary Art Director Leading Digital Creative at Data Axle
New York Roofing Contractors Launch Advanced Roof Installation Solutions
Wowbix Launches Local SEO Growth Program for New Jersey and New York Businesses
Greenridge Global: Positive Developments At Society Pass Inc. (Nasdaq: SOPA) Overlooked By The Market
ABRN and Anthony Venn Dutton Help Global Investors Identify Quality Assets Through the 'Boursemind' Framework
Platinum Price Hits All-Time Highs as Structural Deficits Reshape the Market
FUN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Six Flags Entertainment Corporation f/k/a CopperSteel HoldCo, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SL Green Realty Corp. to Release Fourth Quarter 2025 Financial Results After Market Close on January 28, 2026
WebJoint Announces Strategic Expansion Into Retail Storefront Markets Across the U.S.
Immuneering to Announce 12-Month Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on January 7, 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions